A trader works on the floor of the New York Stock Exchange.
The S&P 500 and Nasdaq Composite took losses to start the week as investors continued their rotation out of technology stocks amid rising bond yields. The Dow Jones Industrial average managed to push into the green as Merck jumped 3%.
The Dow Jones Industrial Average rose about 30 points. The S&P 500 shed 0.35%. The technology-focused Nasdaq Composite was the relative underperformer, dipping 1.15%.
Large tech shares like Apple, Nvidia, Amazon and Microsoft were lower as investors eyed bond yields. A surge in rates to end September knocked highly valued tech stocks. The 10-year Treasury yield was a tad higher Monday, trading around 1.48%.
On the positive side, Tesla rose 3.4% after the company said this weekend that it delivered 241,300 electric vehicles during the third quarter, well above analysts estimates.
Merck shares were up another 5%, following through on an 8% surge on Friday after the drug maker said its oral antiviral treatment developed with Ridgeback Biotherapeutics for Covid-19 reduced the risk of hospitalization or death by 50% for patients with mild or moderate cases.
Airlines stayed in the green after Barclays upgraded the North American Airlines sector to positive from neutral. Southwest rose 2% after an upgrade to overweight from equal weight from the same analyst.
“The on-again, off-again nervousness about Federal monetary policy, the disruption among supply chains and the potential for higher taxes (along with other concerns such as inflation risk and higher taxes) have kept market enthusiasm in check,” wrote John Stoltzfus, Oppenheimer Asset Management’s chief investment strategist, in a note Monday. “Meanwhile rotation and rebalancing efforts along with some profit taking by skeptics, bears and nervous investors account for a significant part of market activity on any given day.”
“Curiously, investor worries about COVID-19 and its variant seem to have begun to play a lessor day-to-day ‘worry role’ in the markets of late than over the course of the summer,” he added.
Friday marked the first trading day of October and the final quarter of 2021. The major averages rose that day on promising data for Merck’s oral treatment for Covid-19, which boosted stocks tied to the economic reopening.
The market rebound followed a rough September plagued by fears of inflation, Federal Reserve tapering and rising interest rates. The 10-year rate topped 1.56% last week, its highest point since June.
The S&P 500 finished the month down 4.8%, breaking a seven-month winning streak. The Dow and the Nasdaq Composite fell 4.3% and 5.3%, respectively, suffering their worst months of the year.
The fourth quarter is typically a good period for stocks, but overhangs like central bank tightening, the debt ceiling, Chinese developer Evergrande and Covid-19 could keep investors cautious. Heading into the fourth quarter, more than half of all S&P stocks are off at least 10%.
The S&P 500 has averaged gains of 3.9% in the fourth quarter and was up four out of every five years since World War II, according to CFRA.
“Q4 2021 will likely record a higher-than-average return. However, investors will need to hang on tight during the typically tumultuous ride in October, which saw 36% higher volatility when compared with the average for the other 11 months,” notes CFRA chief investment strategist Sam Stovall.
One of the first hurdles markets face in the new quarter is Friday’s closely watched employment report, which could spur the Federal Reserve’s decision on when to taper its bond-buying program.
Economists expect about 475,000 jobs were added in September, according to an early consensus figure from FactSet. Just 235,000 payrolls were added in August, about 500,000 less than expected.
“Markets this week are likely to take their cue from economic data as they look to Friday’s employment report for clues as to the strength of the US economy,” said Oppenheimer’s Stoltzfus.
—CNBC’s Patti Domm contributed to this report.